Related references
Note: Only part of the references are listed.Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study
Jiaolin Zhou et al.
CLINICAL CANCER RESEARCH (2021)
STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway
Rui Zhang et al.
CANCER SCIENCE (2020)
Expression of c-Met in Primary and Recurrent Hepatocellular Carcinoma
Yoshinari Asaoka et al.
ONCOLOGY (2020)
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Asaf Zviran et al.
NATURE MEDICINE (2020)
KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma
Xiuzhi Zhang et al.
FRONTIERS IN GENETICS (2020)
Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma
Peter Dietrich et al.
NEOPLASIA (2019)
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O. Kaseb et al.
CLINICAL CANCER RESEARCH (2019)
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Qianwei Ye et al.
MOLECULAR CANCER (2019)
Circulating Tumor DNA and Hepatocellular Carcinoma
Ju Dong Yang et al.
SEMINARS IN LIVER DISEASE (2019)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma
David J. Pinato
ONCOGENE (2018)
Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
Kirill Tsirulnikov et al.
JOURNAL OF CANCER (2018)
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou et al.
LIVER CANCER (2018)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
M. Ignatiadis et al.
ANNALS OF ONCOLOGY (2014)
The genomic landscape of hepatoblastoma and their progenies with HCC-like features
Melanie Eichenmüller et al.
JOURNAL OF HEPATOLOGY (2014)
Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations
Silvia Vilarinho et al.
JOURNAL OF HEPATOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing
Sean P. Cleary et al.
HEPATOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Circulating Tumor Cells and Circulating Tumor DNA
Catherine Alix-Panabieres et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
JS Lee et al.
HEPATOLOGY (2004)
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia
GD Kirk et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
